RecruitingOBSERVATIONAL

A Predictive Score for the Ischemic Etiology of a Transient Diplopia (VASCO-DIP)

This research is investigating temporary double vision, which is when you see two images of one object for a short time. Sometimes, this can be a sign of a serious issue, like a problem with blood flow to the brain, which needs urgent care. Doctors currently find it challenging to quickly identify these serious causes. The study aims to develop a simple scoring system that doctors can use. This score would help them understand if the temporary double vision is likely due to a serious problem, allowing them to make faster and more accurate decisions about the best care for patients. It's hoped this will improve how these conditions are diagnosed and treated, helping patients get the right help sooner.

At a glance

Status

Recruiting

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Enrolment target

220

Start

24 Sep 2015

Estimated completion

23 Dec 2025

Diplopia

What is this study about?

Imagine you suddenly start seeing double, but it only lasts for a short while before going back to normal. While this can be a bit scary, it's a common experience known as 'transient diplopia' in medical terms, meaning temporary double vision. This study, called VASCO-DIP, is specifically looking into these short episodes of double vision.

The main goal of this research is to help doctors better understand why these temporary episodes of double vision happen. Sometimes, they can be due to simple eye problems. Other times, they might be a sign of something more serious, like an issue with blood flow to the brain (which doctors call 'ischemic etiology'). It can be difficult for doctors to tell the difference quickly, especially when urgent treatment might be needed.

To help with this, researchers are trying to create a simple scoring system. This score would use information from a patient's examination to give doctors a clearer idea of whether the double vision is likely caused by a serious problem. The hope is that this new tool will allow doctors to make quicker and more accurate decisions about a patient's care, ensuring those who need urgent attention receive it without delay. This could make a real difference in how temporary double vision is diagnosed and managed.

Key takeaways

This study focuses on temporary double vision.
It aims to create a tool for doctors to quickly spot serious causes.
Participation involves clinical, eye, and nerve check-ups.
No new medications are being tested in this study.
It's for adults aged 18 and over who've had recent temporary double vision.

Who may be eligible?

To be part of this study, you need to be an adult, 18 years old or older. There is no upper age limit, so people of all adult ages can potentially join.

The most important requirement is that you have experienced temporary double vision. This means that at some point within the last 8 days, you saw double, and it only lasted for a short period, less than 24 hours.

Currently, the study description does not list any specific reasons why someone would *not* be able to join, beyond not meeting the above criteria. If you're interested, your doctor will check if you meet all the necessary requirements.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Have you experienced double vision that lasted less than 24 hours?
Did this temporary double vision happen within the last 8 days?
Are you comfortable having physical examinations, including eye and nerve checks?

Answer every question to see your result.

What does participation involve?

This study involves a standard assessment by healthcare professionals. If you decide to take part, doctors will carry out a thorough check of your medical history, as well as eye (ophthalmological) and nerve (neurological) examinations, similar to what you might expect during a regular hospital visit. There are no specific medications involved that are being tested, as this study is about observation and evaluation. The study does not mention specific follow-up appointments or a total duration of participation, but these details would be discussed with you by the study team.

Potential risks and benefits

Participating in this study might help doctors learn more about temporary double vision, which could benefit future patients. There are no new treatments or medications involved, so you won't be exposed to those kinds of risks. The main involvement is undergoing clinical evaluations, which carry the usual small risks associated with medical check-ups. You are always free to change your mind and withdraw from the study at any time without giving a reason, and this will not affect your future medical care.

Locations (2)

Hôpital Bichat
Verified postcode
Paris, France· Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Verified postcode
Paris, France· Recruiting

Common questions

What is 'transient diplopia'?

It's a medical term for double vision that comes and goes quickly, usually lasting less than 24 hours.

Why is this research important?

It aims to help doctors quickly identify serious causes of temporary double vision so patients can get urgent care if needed.

What will I have to do if I join?

You'll have a thorough check-up, including eye and nerve examinations, by medical professionals.

Will I receive any new medicines?

No, this study doesn't test new medicines. It's about developing a way for doctors to better understand your condition.

Can I leave the study once I've joined?

Yes, you can choose to leave the study at any time, and this won't affect your medical care.

How to find out more

Michel Rosenheim, MD, DSc

mrosenheim@fo-rothschild.fr +33148036457 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.